| Original language | English |
|---|---|
| Pages (from-to) | 229-242 |
| Number of pages | 14 |
| Journal | Human Gene Therapy |
| Volume | 8 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 20 1997 |
A phase I study of recombinant adenovirus vector-mediated delivery of an anti-erbB-2 single-chain (sFv) antibody gene for previously treated ovarian and extraovarian cancer patients
Ronald D. Alvarez, David T. Curiel
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Department of Radiation Oncology
- Center of Regenerative Medicine
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Molecular Genetics and Genomics
- Brain Tumor Center
Research output: Contribution to journal › Review article › peer-review
24
Scopus
citations